75 - Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
05 de junho de 202632min
0:00 / 32:46
Discussão do artigo: "Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" de Woyach J JCO 2025
Apresentado por: Dr. Rafael Faust
Discussão por: Dra. Gabriele Ritter, Dr. Eduardo Burlamarqui e Dr. Pedro Moraes.
75 - Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Castnews Index — Castnews Index